An immuno-assay to quantify influenza virus hemagglutinin with correctly folded stalk domains in vaccine preparations

PLoS ONE

Volumn 13, Issue 4, 2018, Pages

  Rajendran, Madhusudan ^a   Sun, Weina ^a   Comella, Phillip ^a   Nachbagauer, Raffael ^a   Wohlbold, Teddy John ^a   Amanat, Fatima ^a   Kirkpatrick, Ericka ^a   Palese, Peter ^a   Krammer, Florian ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC PROTEIN; EPITOPE; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; FUSION PROTEIN; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONFORMATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOASSAY; IMMUNODIFFUSION; INFLUENZA; INFLUENZA VIRUS; MOUSE; NONHUMAN; ANIMAL; BIOSYNTHESIS; CHEMISTRY; GENETICS; HUMAN; IMMUNOLOGY; INFLUENZA A VIRUS; METABOLISM; PH; PROTEIN DOMAIN; PROTEIN FOLDING;

ANIMALS; ANTIBODIES, MONOCLONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; HYDROGEN-ION CONCENTRATION; INFLUENZA A VIRUS; INFLUENZA VACCINES; PROTEIN DOMAINS; PROTEIN FOLDING; RECOMBINANT FUSION PROTEINS;

EID: 85044994495     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0194830     Document Type: Article

References (47)

1. Schild G, Wood J, Newman R. A single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen. Proposals for an assay method for the haemagglutinin content of influenza vaccines. Bull World Health Organ. 1975; 52(2):223-31. PMID: 816480.
2. Wood JM, Schild GC, Newman RW, Seagroatt V. An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: application for potency determinations of inactivated whole virus and subunit vaccines. J Biol Stand. 1977; 5(3):237-47. PMID: 408355.
3. Williams MS. Single-radial-immunodiffusion as an in vitro potency assay for human inactivated viral vaccines. Vet Microbiol. 1993; 37(3-4):253-62. Epub 1993/11/01. PMID: 8116186.
4. Hirst GK. THE QUANTITATIVE DETERMINATION OF INFLUENZA VIRUS AND ANTIBODIES BY MEANS OF RED CELL AGGLUTINATION. J Exp Med. 1942; 75(1):49-64. PMID: 19871167; PubMed Central PMCID: PMCPMC2135212.
5. Minor PD. Assaying the Potency of Influenza Vaccines. Vaccines (Basel). 2015; 3(1):90-104. https://doi.org/10.3390/vaccines3010090 PMID: 26344948; PubMed Central PMCID: PMCPMC4494238.
6. Hobson D, Curry RL, Beare AS, Ward-Gardner A. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg (Lond). 1972; 70 (4):767-77. PMID: 4509641; PubMed Central PMCID: PMCPMC2130285.
7. Ohmit SE, Petrie JG, Cross RT, Johnson E, Monto AS. Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection. J Infect Dis. 2011; 204(12):1879-85. https://doi.org/10.1093/infdis/jir661 PMID: 21998477.
8. Krammer F, Pica N, Hai R, Margine I, Palese P. Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies. J Virol. 2013; 87(12):6542-50. https://doi.org/10.1128/JVI.00641-13 PMID: 23576508; PubMed Central PMCID: PMCPMC3676110.
9. Krammer F. The Quest for a Universal Flu Vaccine: Headless HA 2.0. Cell Host Microbe. 2015; 18 (4):395-7. https://doi.org/10.1016/j.chom.2015.10.003 PMID: 26468743.
10. Yassine HM, Boyington JC, McTamney PM, Wei CJ, Kanekiyo M, Kong WP, et al. Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection. Nat Med. 2015; 21(9):1065-70. https://doi.org/10.1038/nm.3927 PMID: 26301691.
11. Impagliazzo A, Milder F, Kuipers H, Wagner MV, Zhu X, Hoffman RM, et al. A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen. Science. 2015; 349(6254):1301-6. https://doi.org/10.1126/science.aac7263 PMID: 26303961.
12. Krammer F, Margine I, Tan GS, Pica N, Krause JC, Palese P. A carboxy-terminal trimerization domain stabilizes conformational epitopes on the stalk domain of soluble recombinant hemagglutinin substrates. PLoS One. 2012; 7(8):e43603. doi: PONE-D-12-16229 [pii] https://doi.org/10.1371/journal.pone.0043603 PMID: 22928001; PubMed Central PMCID: PMCPMC3426533.
13. Thomson CA, Wang Y, Jackson LM, Olson M, Wang W, Liavonchanka A, et al. Pandemic H1N1 Influenza Infection and Vaccination in Humans Induces Cross-Protective Antibodies that Target the Hemagglutinin Stem. Front Immunol. 2012; 3:87. https://doi.org/10.3389/fimmu.2012.00087 PMID: 22586427; PubMed Central PMCID: PMCPMC3347682.
14. Tan GS, Krammer F, Eggink D, Kongchanagul A, Moran TM, Palese P. A pan-h1 anti-hemagglutinin monoclonal antibody with potent broad-spectrum efficacy in vivo. J Virol. 2012; 86(11):6179-88. doi: JVI.00469-12 [pii] https://doi.org/10.1128/JVI.00469-12 PMID: 22491456.
15. Throsby M, van den Brink E, Jongeneelen M, Poon LL, Alard P, Cornelissen L, et al. Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. PLoS One. 2008; 3(12):e3942. Epub 2008/12/17. https://doi.org/10.1371/journal.pone.0003942 PMID: 19079604; PubMed Central PMCID: PMCPMC2596486.
16. Ekiert DC, Friesen RH, Bhabha G, Kwaks T, Jongeneelen M, Yu W, et al. A highly conserved neutralizing epitope on group 2 influenza A viruses. Science. 2011; 333(6044):843-50. doi: science.1204839 [pii] https://doi.org/10.1126/science.1204839 PMID: 21737702.
17. Hai R, Krammer F, Tan GS, Pica N, Eggink D, Maamary J, et al. Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypes. J Virol. 2012; 86 (10):5774-81. doi: JVI.00137-12 [pii] https://doi.org/10.1128/JVI.00137-12 PMID: 22398287.
18. Chen CJ, Ermler ME, Tan GS, Krammer F, Palese P, Hai R. Influenza A viruses expressing intra- or inter-group chimeric hemagglutinins. J Virol. 2016. https://doi.org/10.1128/JVI.03060-15 PMID: 26764009.
19. Wohlbold TJ, Chromikova V, Tan GS, Meade P, Amanat F, Comella P, et al. Hemagglutinin Stalk- and Neuraminidase-Specific Monoclonal Antibodies Protect against Lethal H10N8 Influenza Virus Infection in Mice. J Virol. 2015; 90(2):851-61. https://doi.org/10.1128/JVI.02275-15 PMID: 26512088.
20. Margine I, Palese P, Krammer F. Expression of Functional Recombinant Hemagglutinin and Neuraminidase Proteins from the Novel H7N9 Influenza Virus Using the Baculovirus Expression System. J Vis Exp. 2013;(81). https://doi.org/10.3791/51112 PMID: 24300384.
21. Dinca L, Neuwirth S, Schulman J, Bona C. Induction of antihemagglutinin antibodies by polyclonal antiidiotype antibodies. Viral Immunol. 1993; 6(1):75-84. https://doi.org/10.1089/vim.1993.6.75 PMID: 8476510.
22. Heaton NS, Leyva-Grado VH, Tan GS, Eggink D, Hai R, Palese P. In vivo bioluminescent imaging of influenza a virus infection and characterization of novel cross-protective monoclonal antibodies. J Virol. 2013; 87(15):8272-81. https://doi.org/10.1128/JVI.00969-13 PMID: 23698304; PubMed Central PMCID: PMCPMC3719835.
23. Dreyfus C, Laursen NS, Kwaks T, Zuijdgeest D, Khayat R, Ekiert DC, et al. Highly conserved protective epitopes on influenza B viruses. Science. 2012; 337(6100):1343-8. doi: science.1222908 [pii] https://doi.org/10.1126/science.1222908 PMID: 22878502.
24. Cotter CR, Jin H, Chen Z. A single amino acid in the stalk region of the H1N1pdm influenza virus HA protein affects viral fusion, stability and infectivity. PLoS Pathog. 2014; 10(1):e1003831. https://doi.org/10.1371/journal.ppat.1003831 PMID: 24391498; PubMed Central PMCID: PMCPMC3879363.
25. Yang H, Carney P, Stevens J. Structure and Receptor binding properties of a pandemic H1N1 virus hemagglutinin. PLoS Curr. 2010; 2:RRN1152. Epub 2010/03/31. https://doi.org/10.1371/currents.RRN1152 PMID: 20352039; PubMed Central PMCID: PMCPMC2846141.
26. Hong M, Lee PS, Hoffman RM, Zhu X, Krause JC, Laursen NS, et al. Antibody recognition of the pandemic H1N1 Influenza virus hemagglutinin receptor binding site. J Virol. 2013; 87(22):12471-80. Epub 2013/09/13. https://doi.org/10.1128/JVI.01388-13 PMID: 24027321; PubMed Central PMCID: PMCPMC3807900.
27. Wan H, Gao J, Xu K, Chen H, Couzens LK, Rivers KH, et al. Molecular basis for broad neuraminidase immunity: conserved epitopes in seasonal and pandemic H1N1 as well as H5N1 influenza viruses. J Virol. 2013; 87(16):9290-300. Epub 2013/06/21. https://doi.org/10.1128/JVI.01203-13 PMID: 23785204; PubMed Central PMCID: PMCPMC3754050.
28. Wohlbold TJ, Podolsky KA, Chromikova V, Kirkpatrick E, Falconieri V, Meade P, et al. Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes. Nat Microbiol. 2017; 2(10):1415-24. Epub 2017/08/23. https://doi.org/10.1038/s41564-017-0011-8 PMID: 28827718.
29. Duehr J, Wohlbold TJ, Oestereich L, Chromikova V, Amanat F, Rajendran M, et al. Novel Cross-Reactive Monoclonal Antibodies against Ebolavirus Glycoproteins Show Protection in a Murine Challenge Model. J Virol. 2017; 91(16). Epub 2017/06/09. https://doi.org/10.1128/JVI.00652-17 PMID: 28592526; PubMed Central PMCID: PMCPMC5533894.
30. Gamblin SJ, Haire LF, Russell RJ, Stevens DJ, Xiao B, Ha Y, et al. The structure and receptor binding properties of the 1918 influenza hemagglutinin. Science. 2004; 303(5665):1838-42. Epub 2004/02/07. https://doi.org/10.1126/science.1093155 PMID: 14764886.
31. Laver WG, Valentine RC. Morphology of the isolated hemagglutinin and neuraminidase subunits of influenza virus. Virology. 1969; 38(1):105-19. PMID: 5784043.
32. Krammer F, Palese P. Influenza virus hemagglutinin stalk-based antibodies and vaccines. Curr Opin Virol. 2013; 3(5):521-30. https://doi.org/10.1016/j.coviro.2013.07.007 PMID: 23978327; PubMed Central PMCID: PMCPMC3804342.
33. Ekiert DC, Wilson IA. Broadly neutralizing antibodies against influenza virus and prospects for universal therapies. Curr Opin Virol. 2012; 2(2):134-41. Epub 2012/04/10. https://doi.org/10.1016/j.coviro.2012.02.005 PMID: 22482710; PubMed Central PMCID: PMCPMC3368890.
34. Okuno Y, Isegawa Y, Sasao F, Ueda S. A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains. J Virol. 1993; 67(5):2552-8. Epub 1993/05/01. PMID: 7682624; PubMed Central PMCID: PMCPMC237575.
35. Sui J, Hwang WC, Perez S, Wei G, Aird D, Chen LM, et al. Structural and functional bases for broadspectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol. 2009; 16(3):265-73 Epub 2009/02/24. https://doi.org/10.1038/nsmb.1566 PMID: 19234466; PubMed Central PMCID: PMCPMC2692245.
36. Ekiert DC, Bhabha G, Elsliger MA, Friesen RH, Jongeneelen M, Throsby M, et al. Antibody recognition of a highly conserved influenza virus epitope. Science. 2009; 324(5924):246-51. https://doi.org/10.1126/science.1171491 PMID: 19251591; PubMed Central PMCID: PMCPMC2758658.
37. Pavlovic B, Cvijetic N, Dragacevic L, Ivkovic B, Vujic Z, Kuntic V. Direct UV Spectrophotometry and HPLC Determination of Triton X-100 in Split Virus Influenza Vaccine. J AOAC Int. 2016; 99(2):396-400. https://doi.org/10.5740/jaoacint.15-0201 PMID: 26960682.
38. Scholtissek C. Stability of infectious influenza A viruses at low pH and at elevated temperature. Vaccine. 1985; 3(3 Suppl):215-8. Epub 1985/09/01. PMID: 4060851.
39. Epand RM, Epand RF. Thermal denaturation of influenza virus and its relationship to membrane fusion. Biochem J. 2002; 365(Pt 3):841-8. Epub 2002/05/08. https://doi.org/10.1042/BJ20020290 PMID: 11994048; PubMed Central PMCID: PMCPMC1222734.
40. Zhang W, Qi J, Shi Y, Li Q, Gao F, Sun Y, et al. Crystal structure of the swine-origin A (H1N1)-2009 influenza A virus hemagglutinin (HA) reveals similar antigenicity to that of the 1918 pandemic virus. Protein Cell. 2010; 1(5):459-67. Epub 2011/01/05. https://doi.org/10.1007/s13238-010-0059-1 PMID: 21203961; PubMed Central PMCID: PMCPMC4875136.
41. Xu R, McBride R, Nycholat CM, Paulson JC, Wilson IA. Structural characterization of the hemagglutinin receptor specificity from the 2009 H1N1 influenza pandemic. J Virol. 2012; 86(2):982-90. Epub 2011/11/11. https://doi.org/10.1128/JVI.06322-11 PMID: 22072785; PubMed Central PMCID: PMCPMC3255799.
42. Yang H, Chang JC, Guo Z, Carney PJ, Shore DA, Donis RO, et al. Structural stability of influenza A (H1N1)pdm09 virus hemagglutinins. J Virol. 2014; 88(9):4828-38. https://doi.org/10.1128/JVI.02278-13 PMID: 24522930; PubMed Central PMCID: PMCPMC3993803.
43. Desbien AL, Van Hoeven N, Reed SJ, Casey AC, Laurance JD, Baldwin SL, et al. Development of a high density hemagglutinin protein microarray to determine the breadth of influenza antibody responses. Biotechniques. 2013; 54(6):345-8. Epub 2013/06/12. https://doi.org/10.2144/000114041 PMID: 23750544.
44. Nachbagauer R, Kinzler D, Choi A, Hirsh A, Beaulieu E, Lecrenier N, et al. A chimeric haemagglutininbased influenza split virion vaccine adjuvanted with AS03 induces protective stalk-reactive antibodies in mice. npj Vaccines. 2016; 1(1). https://doi.org/10.1038/npjvaccines.2016.15 PMID: 29250436
45. Krammer F, Hai R, Yondola M, Tan GS, Leyva-Grado VH, Ryder AB, et al. Assessment of influenza virus hemagglutinin stalk-based immunity in ferrets. J Virol. 2014; 88(6):3432-42. Epub 2014/01/10. https://doi.org/10.1128/JVI.03004-13 PMID: 24403585; PubMed Central PMCID: PMCPMC3957929.
46. Nachbagauer R, Liu W-C, Choi A, Wohlbold TJ, Atlas T, Rajendran M, et al. A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies. npj Vaccines. 2017; 2(1). https://doi.org/10.1038/s41541-017-0026-4 PMID: 29263881
47. Corti D, Voss J, Gamblin SJ, Codoni G, Macagno A, Jarrossay D, et al. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science. 2011; 333 (6044):850-6. Epub 2011/07/30. https://doi.org/10.1126/science.1205669 PMID: 21798894.